Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2012 1
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
[Recommendations for diagnosis and pharmacological management in pediatric patients with SARS-CoV-2 (COVID-19) infection].
Pavez Azurmendi D, González Muñoz C, Bernal Ortiz F, Pérez Pérez R, Acuña Ávila M, Rosales Chacón R, Perillán Torres J, Quijarro Santibáñez P, Scheu Goncalves C, María Fuenzalida L, Pérez Godoy J, Arancibia JM, Impellizzeri P, Pinto Claude ME. Pavez Azurmendi D, et al. Among authors: perez godoy j. Rev Chilena Infectol. 2020 Dec;37(6):625-645. doi: 10.4067/S0716-10182020000600625. Rev Chilena Infectol. 2020. PMID: 33844804 Free article. Spanish. No abstract available.
[Recommendations for the study and pharmacological management in adult patients with suspected infection by SARS-CoV-2 (COVID-19)].
Pérez Godoy J, Rosales Chacón R, Bernal Ortiz F, Luengo Messen C, Arancibia Henríquez JM, Pavez Azurmendi D, González Muñoz C, Arancibia Hernández F, Riquelme Oyarzún R, Pérez Pérez R, Acuña Ávila M, Chanqueo Cornejo L, Regueira Heskia T, Fuenzalida LM, Hernández Mazurek R, Arias Lucero M, Impellizzeri Navarro P, Paredes Kunst C, Pinto Claude ME. Pérez Godoy J, et al. Rev Chilena Infectol. 2020 Dec;37(6):646-666. doi: 10.4067/S0716-10182020000600646. Rev Chilena Infectol. 2020. PMID: 33844805 Free article. Spanish. No abstract available.
Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients: week-192 overall and subgroup analyses from STARTMRK.
DeJesus E, Rockstroh JK, Lennox JL, Saag MS, Lazzarin A, Zhao J, Wan H, Rodgers AJ, Walker ML, Miller M, DiNubile MJ, Nguyen BY, Teppler H, Leavitt R, Sklar P; STARTMRK Investigators. DeJesus E, et al. HIV Clin Trials. 2012 Jul-Aug;13(4):228-32. doi: 10.1310/hct1304-228. HIV Clin Trials. 2012. PMID: 22849964 Clinical Trial.
Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses.
Lennox JL, Dejesus E, Berger DS, Lazzarin A, Pollard RB, Ramalho Madruga JV, Zhao J, Wan H, Gilbert CL, Teppler H, Rodgers AJ, Barnard RJ, Miller MD, Dinubile MJ, Nguyen BY, Leavitt R, Sklar P; STARTMRK Investigators. Lennox JL, et al. J Acquir Immune Defic Syndr. 2010 Sep;55(1):39-48. doi: 10.1097/QAI.0b013e3181da1287. J Acquir Immune Defic Syndr. 2010. PMID: 20404738 Free PMC article. Clinical Trial.
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.
Lennox JL, DeJesus E, Lazzarin A, Pollard RB, Madruga JV, Berger DS, Zhao J, Xu X, Williams-Diaz A, Rodgers AJ, Barnard RJ, Miller MD, DiNubile MJ, Nguyen BY, Leavitt R, Sklar P; STARTMRK investigators. Lennox JL, et al. Lancet. 2009 Sep 5;374(9692):796-806. doi: 10.1016/S0140-6736(09)60918-1. Epub 2009 Aug 3. Lancet. 2009. PMID: 19647866 Clinical Trial.